On May 22, 2009, Alabama’s Attorney General Troy King announced an additional $89 million in settlements in ongoing litigation against a total of 72 pharmaceutical companies accused of defrauding the state’s Medicaid system by overcharging for drugs. Beasley Allen is representing the state in the Average Wholesale Price (AWP) litigation, and has already secured settlements totaling $34.75 million and jury verdicts of more than $352.4 million against pharmaceutical manufacturer defendants. The latest round of settlements resolves Alabama’s Medicaid fraud cases against six defendants comprised of groups of drug manufacturers, including Abbott Laboratories, Inc.; Aventis Pharmaceutical L.P., Aventis Behring L.L.C., ZLB Behring L.L.C. and Sanofi-Synthelabo, Inc.; TEVA Pharmaceuticals U.S.A., Inc., IVAX Corporation, IVAX Pharmaceuticals Inc., and Barr Laboratories, Inc.; Shering-Plough/Warrick Companies; Forest Laboratories Inc. and Forest Pharmaceuticals Inc.; and Baxter International Inc. and Baxter Healthcare Corporation.